Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-21-000206
Filing Date
2021-10-05
Accepted
2021-10-05 08:52:33
Documents
1
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4029
  Complete submission text file 0001013762-21-000206.txt   5413
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 DURHAM TERRACE LONDON X0 W25PB
Business Address
Feldmann Marc (Reporting) CIK: 0001832327 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 211305244